Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPCs for Chronic Discogenic Lumbar Back Pain
NCT01290367Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Aug 2011
- Primary completion
- Jul 2013
- Countries
- 2
01
Overview
A Phase 2 trial of rexlemestrocel-l in degenerative disc disease (DDD), sponsored by Mesoblast Ltd. Started Aug 2011; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT01290367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290367.